User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Feb 16 2017 12:24 IST RSS 2.0
 
1 to 20 of 2,765    
BUZZ-India's Dr. Reddy's Labs hits over 1-year low; firm's drug infringes U.S. patents 16.2.2017 Sify Finance
** Shares of Dr Reddy's Laboratories fall as much as 3.9 pct, their lowest since Jan 22, 2016
Also found in: [+]
Healthcare and patient groups oppose patents on crucial hepatitis C drugs 15.2.2017 TOI: India
Also found in: [+]
NGOs strive to make hepatitis C drugs affordable 15.2.2017 TOI: India
Also found in: [+]
USTR urged not to demand excessive IP enforcement in India 14.2.2017 ET: Infotech
MSF said countries should not be penalised or discouraged from making use of the public health safeguards that are intended to protect access.
Also found in: [+]
US pharma sector demands keeping India in patent violator list 14.2.2017 ET: Pharma
PhRMA in a submission requested US Trade Representative (USTR) to continue to keep India on the Priority Watch List in the 2017 Special 301 Report.
Also found in: [+]
MNC pharma lobby pushes for single drug authority here 9.2.2017 ET: Pharma
The OPPI, which represents 22 pharma companies, including Abbott, Pfizer, Novartis, Novo Nordisk and Sanofi, also wants specialised patent courts for fast disposal of patents and IP disputes.
Also found in: [+]
Kerala tribe to get fiscal boost for sharing wonder energy plant 7.2.2017 DNA: Health
South India's Kani tribe, which discovered a life-promoting plant Arogyapacha, may now hold the patent to this valuable indigenous species
Also found in: [+]
US Court rules in favour of Mylan for Copaxone patents: Natco 31.1.2017 ET: Pharma
In December 2016, the US Patent and Trademark Office (PTO) had ruled in favour of Mylan and three patents related to Copaxone 40 mg/mL were found unpatentable.
Also found in: [+]
HC allows Indian firm to export drug in which Bayer has patent 29.1.2017 ET: Pharma
Bayer admitted before the court that it has not used its patents for commercial exploitation in India while Ajanta had launched its drug back in 2009-10 and was exporting it since then to various countries.
Also found in: [+]
View: Govt should reduce over dependence on Chinese imports of pharma raw materials 19.1.2017 ET: Pharma
Industry is expecting an impetus to pharma sector keeping in line with the government’s mantra of introducing big bang reforms.
Also found in: [+]
Activists cry foul over new HIV drug monopoly 27.12.2016 ET: Pharma
Only one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market, because of a licensing agreement with Viiv Healthcare
Also found in: [+]
Bayer gets over compulsory licence 14.11.2016 ET: Pharma
“India is a large market and we will get through the challenges that are there. It is never easy but we also see huge potential in the Indian market which we cannot ignore.”
Also found in: [+]
IISC team designs 'salt' to combat bacterial infections 1.11.2016 TOI: Bangalore Times
While a combination of antibacterial and antimicrobial medications are used to treat infections, these can differ in their properties, some of which may not have the desired result. A physical mixture of the two drugs may not be very effective, said experts. A team from the Indian Institute of Science (IISc), Bengaluru, have addressed this problem by designing a solid in the form of a salt, which is a combination of two known drugs.
Also found in: [+]
Sitharaman discusses social security pact, IPR at Indo-US trade forum 20.10.2016 DNA: India
India, on Thursday, "strongly" urged the US to engage in negotiations for the Totalisation Agreement or Social Security pact as its absence is restricting the movement of domestic IT professionals in America. The issue of Totalisation Agreement was again taken up during a delegation-level meeting in New Delhi between the two nations. US Trade Representative Michael Froman is leading the delegation for the 10th India-US Trade Policy Forum (TPF) meeting. "We very clearly identified this as one of the non-tariff measures...which is restricting the movement of IT professionals. "We have strongly urged the US to engage in negotiations for signing of a Totalisation Agreement. It is being heard and I hope there will be a positive response from their side," Commerce and Industry Minister Nirmala Sitharaman told reporters after the delegation-level meeting. India wants early conclusion of the social security agreement with the US. The US has entered into Totalisation Agreement with several nations for the purpose ...
Also found in: [+]
India urges US to discuss pact to avoid double taxation 20.10.2016 TOI: India
India today "strongly" urged the US to engage in negotiations for the Totalisation Agreement or Social Security pact as its absence is restricting the movement of domestic IT professionals in America and also resulting in double taxation..
Also found in: [+]
Sun Pharma partners ICGEB to develop safer, cheaper dengue vaccine 20.10.2016 ET: Pharma
This is the Mumbai-based company’s second collaboration focussed on the mosquito-borne virus, the first being its pact to develop a botanical drug ‘Cipa’.
Also found in: [+]
India to be amongst top five global pharma innovation hubs by 2020: Assocham 29.8.2016 Sify Finance
[India], Aug 29 (ANI): To push India into top five pharmaceutical innovation hubs by 2020 and establish global presence by launching one out of every five to 10 drugs discovered in India at global
Also found in: [+]
Swamy attacks CEA Arvind Subramanian again 21.8.2016 TOI: Home
Swamy had in late June trained his guns on Arvind Subramanian and demanded his sacking for allegedly taking anti-India stance when he was an IMF economist at Washington prior to joining the Finance Ministry. Arun Jaitley had debunked Swamy's call saying "Government has full confidence in CEA."
Also found in: [+]
​ Pfizer plans to bring more global drugs to India 15.8.2016 ET: Pharma
Although the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which have expired, to the domestic market.
Also found in: [+]
Expanding markets, launching new products for growth: Wockhardt 14.8.2016 ET: Pharma
In the last 10 years, global research in antibiotics has declined and the number of patents filed globally has gone down by 60 per cent.
Also found in: [+]
1 to 20 of 2,765